Virus variation has been the bane of Covid-19 control. No sooner has one wave of infection passed than a second arrives, evading prior immunity and even vaccines. Monoclonal antibody drugs effective ...
In a recent study published in the International Journal of Molecular Sciences, researchers reported that lentiviral pseudovirions pseudotyped with severe acute respiratory syndrome coronavirus 2 ...
High-resolution images provide clarity into how viral proteins are separated by a protease, an important step during virus replication that is targeted by an approved COVID-19 drug. UNIVERSITY PARK, ...
Novel autophagy research traces new mammalian pathways and reveals unexpected impact of SARS-CoV-2 infection. The intricate biological process known as autophagy plays a vital role in keeping our ...
HILDEN, Germany & GERMANTOWN, Md.--(BUSINESS WIRE)--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced it will develop a new QIAstat-Dx test kit to differentiate the novel SARS-CoV-2 ...
COLLEGE STATION, TX / ACCESSWIRE / August 24, 2023 / Biogenysis, Inc. (OTC PINK:ENZC) (or the "Company"). Biogenysis, a subsidiary of Enzolytics, Inc., announces the progress of its Patent Cooperation ...
Journal of Public Health, Vol. 30, No. 3 (September 2008), pp. 234-244 (11 pages) Background Severe Acute Respiratory Syndrome (SARS) was first reported in November 2002 in China, and spreads to about ...
Coronavirus disease-2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the mode of transmission of which is mainly through respiratory droplets and aerosols.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback